Biocon’s standalone margin drops 3.37 points sequentially
Costs rose 7.29% QoQ against 3.27% revenue growth, while other income supplied 92.7% of pre-tax profit.
Filed 05 Aug 2026, 16:51 IST · after market close · Biocon Ltd (BIOCON)
Key takeaways
- Standalone operating margin narrowed 3.37 percentage points QoQ as expenses grew 7.29%, faster than revenue at 3.27%.
- Year-on-year operating margin improved 5.90 percentage points as revenue grew 16.27%, ahead of expenses at 9.14%, while interest fell 69.22%.
- Other income accounted for 92.7% of pre-tax profit, making the Rs 52.2 cr net profit less representative of operating earnings.
Price around the results
Sequential margin reset despite higher revenue
Biocon’s standalone revenue grew 3.27% QoQ, but expenses rose 7.29%, reducing operating profit by 23.33% and narrowing operating margin from 13.11% to 9.74%. The quarter still marked a year-on-year operating recovery: revenue grew 16.27% while expenses increased 9.14%, lifting margin by 5.90 percentage points. Lower interest expense, down 69.22% YoY, also supported the return to a net profit of Rs 52.2 cr from a loss in the year-earlier quarter.
Other income drove most of pre-tax profit
Other income rose 109.03% QoQ to Rs 64.8 cr and represented 92.7% of pre-tax profit. That contribution explains why pre-tax profit increased 21.78% sequentially even as operating profit fell. The tax rate also rose 14.17 percentage points QoQ, which limited the benefit to net profit.
Margin remains below the healthcare peer set
Biocon’s 9.74% operating margin was 12.80 percentage points below the 22.54% median among 42 Healthcare peers that had reported the same quarter. It ranked third from the bottom on this measure. The sequential decline follows a 13.11% margin in Q4FY26, although the current margin remains above 3.84% in Q1FY26.
Results filed after market close
The results were filed after market close, so there is no current-session reaction to assess. Across the eight recent result events in the history provided, the stock fell after five and rose after three, with a median absolute move of 1.43%.
Q1FY27 at a glance
Standalone figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 | Q4FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹625 cr | ₹605 cr | +3.27% | +16.27% |
| Other income | ₹65 cr | ₹31 cr | +109.03% | +5.71% |
| Expenses | ₹564 cr | ₹525 cr | +7.29% | +9.14% |
| Operating profit | ₹61 cr | ₹79 cr | -23.33% | +195.15% |
| Operating margin (%) | 9.74% | 13.11% | — | — |
| Interest | ₹17 cr | ₹17 cr | +3.59% | -69.22% |
| Depreciation | ₹38 cr | ₹36 cr | +6.08% | +15.32% |
| Profit before tax | ₹70 cr | ₹57 cr | +21.78% | — |
| Tax | ₹18 cr | ₹6 cr | +176.56% | +2428.57% |
| Net profit | ₹52 cr | ₹51 cr | +2.35% | — |
| EPS (₹) | ₹0.32 | ₹0.32 | +0.00% | — |
Operating margin of 9.74% compares with a Healthcare sector median of 22.54% across 42 peers that have reported Q1FY27.
What to watch
- Whether operating margin recovers from 9.74% after falling from 13.11% QoQ.
- Whether expenses grow slower than revenue after rising 7.29% versus 3.27% QoQ.
- Whether other income remains a dominant contributor after accounting for 92.7% of pre-tax profit.